Article

Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.

2020-08-18

Abstract excerpt

<h4>Background: </h4> Pharmacological therapies of proven efficacy in coronavirus disease 2019 (COVID-19) are still lacking. We have identified IFNβ-1a as the most promising drug to be repurposed for COVID-19. The rationale relies on the evidence of IFNβ anti-viral activity in vitro against SARS-CoV-2 and animal models resembling SARS-CoV-2 infection and on a recent clinical trial where IFNβ was indicated as the k...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fec48268-0efa-5f90-9ae2-9aae853e284a
DOI: 10.21203/rs.3.rs-42306/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Interferon β-1a (IFNβ-1a) in COVID-19 patients (INTERCOP): study protocol for a randomized controlled trial.DOI 10.21203/rs.3.rs-42306/v1Read

Safety, tolerability, bioavailability, and biological activity of inhaled interferon-α2b in healthy adults: The IN2COVID phase 1 randomized trialSemantic proximity Read

REGEN-COV Antibody Combination in Outpatients With COVID-19 – Phase 1/2 ResultsSemantic proximity Read

Favipiravir and/or Nitazoxanide: a randomized, double-blind, 2x2 design, placebo-controlled trial of early therapy in COVID-19 (FANTAZE).Semantic proximity Read

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trialSemantic proximity Read

A snapshot of the ongoing clinical research on COVID-19Semantic proximity Read

Outcomes evaluated in controlled clinical trials on the management of COVID-19: A methodological systematic reviewSemantic proximity Read

Therapeutic effectiveness of interferon-alpha 2b against COVID-19: the Cuban experienceSemantic proximity Read

Efficacy and safety of sofosbuvir plus daclatasvir or ravidasvir in patients with COVID-19: A randomized controlled trial.Semantic proximity Read

Human Umbilical Cord-Derived Mesenchymal Stem Cell Therapy in COVID-19 Patients: A Phase 1 Clinical TrialSemantic proximity Read

DEFINE: A Phase IIa Randomised Controlled Trial to Evaluate Repurposed Treatments for COVID-19Semantic proximity Read

Reduced IFNL1 and/or IFNL2, but not IFNL3 is associated with worse outcome in patients with COVID-19.Semantic proximity Read

Treatment of COVID-19 patients with a SARS-CoV-2-specific siRNA-peptide dendrimer formulationSemantic proximity Read